GSA Capital Partners’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-486,568
| Closed | -$154K | – | 1421 |
|
|
2022
Q3 | $154K | Buy |
+486,568
| New | +$154K | 0.02% | 1288 |
|
|
2022
Q2 | – | Sell |
-54,370
| Closed | -$39K | – | 1359 |
|
|
2022
Q1 | $39K | Buy |
+54,370
| New | +$39K | 0.01% | 1345 |
|
|
2021
Q4 | – | Sell |
-254,376
| Closed | -$733K | – | 1382 |
|
|
2021
Q3 | $733K | Buy |
+254,376
| New | +$733K | 0.07% | 461 |
|
|
2021
Q1 | – | Sell |
-128,626
| Closed | -$360K | – | 1066 |
|
|
2020
Q4 | $360K | Buy |
128,626
+38,963
| +43% | +$109K | 0.06% | 637 |
|
|
2020
Q3 | $225K | Buy |
+89,663
| New | +$225K | 0.04% | 931 |
|
|
2019
Q4 | – | Sell |
-26,187
| Closed | -$103K | – | 1405 |
|
|
2019
Q3 | $103K | Buy |
+26,187
| New | +$103K | 0.01% | 1275 |
|
|
2016
Q2 | – | Sell |
-10,881
| Closed | -$98K | – | 1714 |
|
|
2016
Q1 | $98K | Buy |
+10,881
| New | +$98K | 0.01% | 1584 |
|